19 May 2013
Keywords: positive, phase, data, medicure, iv, mc-1, flagship
Article | 27 September 2004
Medicure's flagship drug MC-1, a naturally-occurring small molecule, has successfully completed a Phase I trial to evaluate its safety and
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
27 September 2004
17 May 2013
© 2013 thepharmaletter.com